116 related articles for article (PubMed ID: 3801360)
1. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome.
Magos AL; Brewster E; Singh R; O'Dowd T; Brincat M; Studd JW
Br J Obstet Gynaecol; 1986 Dec; 93(12):1290-6. PubMed ID: 3801360
[TBL] [Abstract][Full Text] [Related]
2. Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo controlled study.
Magos AL; Brincat M; Studd JW
Br Med J (Clin Res Ed); 1986 Jun; 292(6536):1629-33. PubMed ID: 3087550
[TBL] [Abstract][Full Text] [Related]
3. A placebo-controlled trial of ethinyl oestradiol and norethisterone in climacteric women.
Nordin BE; Jones MM; Crilly RG; Marshall DH; Brooke R
Maturitas; 1980 Oct; 2(3):247-51. PubMed ID: 7003315
[TBL] [Abstract][Full Text] [Related]
4. Does low-dose, transdermal, norethisterone acetate reliably cause endometrial transformation in postmenopausal oestrogen-users?
Fraser D; Whitehead M; Schenkel L; Pryse-Davies J
Maturitas; 1993 Jan; 16(1):23-30. PubMed ID: 8429801
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen.
Mattsson LA; Samsioe G
Acta Obstet Gynecol Scand Suppl; 1985; 130():53-8. PubMed ID: 3859976
[TBL] [Abstract][Full Text] [Related]
6. Negative mood changes during hormone replacement therapy: a comparison between two progestogens.
Björn I; Bixo M; Nöjd KS; Nyberg S; Bäckström T
Am J Obstet Gynecol; 2000 Dec; 183(6):1419-26. PubMed ID: 11120505
[TBL] [Abstract][Full Text] [Related]
7. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone.
Watson NR; Studd JW; Savvas M; Garnett T; Baber RJ
Lancet; 1989 Sep; 2(8665):730-2. PubMed ID: 2570971
[TBL] [Abstract][Full Text] [Related]
8. Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints.
Hellberg D; Nilsson S
Maturitas; 1984 Apr; 5(4):233-43. PubMed ID: 6429481
[TBL] [Abstract][Full Text] [Related]
9. The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study.
Leather AT; Studd JW; Watson NR; Holland EF
Gynecol Endocrinol; 1999 Feb; 13(1):48-55. PubMed ID: 10368798
[TBL] [Abstract][Full Text] [Related]
10. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
[TBL] [Abstract][Full Text] [Related]
11. Endometrial and menstrual response to subcutaneous oestradiol and testosterone implants and continuous oral progestogen therapy in post-menopausal women.
Magos AL; Brincat M; O'Dowd T; Wardle PJ; Schlesinger P; Studd JW
Maturitas; 1985 Nov; 7(4):297-302. PubMed ID: 4079826
[TBL] [Abstract][Full Text] [Related]
12. Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints.
Sporrong T; Hellgren M; Samsioe G; Mattsson LA
Br J Obstet Gynaecol; 1988 Oct; 95(10):1042-8. PubMed ID: 3056498
[TBL] [Abstract][Full Text] [Related]
13. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric.
Montgomery JC; Appleby L; Brincat M; Versi E; Tapp A; Fenwick PB; Studd JW
Lancet; 1987 Feb; 1(8528):297-9. PubMed ID: 2880114
[TBL] [Abstract][Full Text] [Related]
14. Treatment of the premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone.
Prescott P
Br Med J (Clin Res Ed); 1986 Aug; 293(6544):451. PubMed ID: 3091153
[No Abstract] [Full Text] [Related]
15. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
16. Endometrial changes after long-term use of continuous oestrogen and cyclic progestogen.
Fink BJ
Maturitas; 1984 Apr; 5(4):277-80. PubMed ID: 6738374
[TBL] [Abstract][Full Text] [Related]
17. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
Spencer C; Crook D; Ross D; Cooper A; Whitehead M; Stevenson J
Br J Obstet Gynaecol; 1999 Sep; 106(9):948-53. PubMed ID: 10492107
[TBL] [Abstract][Full Text] [Related]
18. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy.
Hammarbäck S; Bäckström T; Holst J; von Schoultz B; Lyrenäs S
Acta Obstet Gynecol Scand; 1985; 64(5):393-7. PubMed ID: 4061059
[TBL] [Abstract][Full Text] [Related]
19. Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects.
Alexandersen P; Byrjalsen I; Christiansen C
BJOG; 2000 Mar; 107(3):356-64. PubMed ID: 10740332
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ovulation with oral progestins--effectiveness in premenstrual syndrome.
West CP
Eur J Obstet Gynecol Reprod Biol; 1990; 34(1-2):119-28. PubMed ID: 2303145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
